Hemagen Diagnostics, Inc. (HMGN)
OTCMKTS · Delayed Price · Currency is USD
0.0002
0.00 (0.00%)
At close: Apr 24, 2026
Hemagen Diagnostics Market Cap
Hemagen Diagnostics has a market cap or net worth of $3.1 thousand as of May 8, 2026. Its market cap has decreased by -98.00% in one year.
Market Cap
3.10K
Enterprise Value
n/a
Revenue
4.04M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since May 23, 1996, Hemagen Diagnostics's market cap has decreased from 20.30M to 3.10K, a decrease of -99.98%. That is a compound annual growth rate of -25.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 24, 2026 | 3.10K | - |
| Dec 9, 2025 | 3.10K | 100.00% |
| Dec 28, 2022 | 1.55K | -98.59% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 23, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| TetraLogic Pharmaceuticals | 4.86K |
| Panbela Therapeutics | 4.86K |
| Kaleido Biosciences | 4.26K |
| ONE Bio | 4.19K |
| Baseline Productions | 4.11K |
| Xeno Transplants | 4.04K |
| MetaStat | 3.53K |
| Affimed | 3.28K |